Company news
BioCardia, Inc. news in 2020
BioCardia, Inc.'s news releases, calls and decks from 2020, newest first.
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
December 29, 2020
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed
December 16, 2020
BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
December 15, 2020
BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
December 13, 2020
BioCardia Reports Third Quarter 2020 Financial Results and Business Highlights
November 9, 2020
BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights
August 12, 2020
BioCardia To Conduct Mid-Year Conference Call and Corporate Update August 13, 2020
August 6, 2020
BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 Era
June 30, 2020
BioCardia Announces Activation of Pivotal Trial Studying CardiAMP Cell Therapy Trial to Treat Chronic Myocardial Ischemia
June 30, 2020
BioCardia Announces Pricing of $10 Million Public Offering
June 16, 2020
BioCardia Reports First Quarter 2020 Financial Results and Business Highlights
May 14, 2020
BioCardia Announces Positive Preclinical Results Supporting Investigational New Drug Application for Anti-Inflammatory Cell Therapy in Heart Failure
May 4, 2020
Biocardia Announces FDA-Recommended Modifications to Primary Endpoint for Cardiamp Cell Therapy Heart Failure Trial to Support Marketing Approval
April 29, 2020
BioCardia Awarded New U.S. Patent Covering Helix System for Local Biotherapeutic Delivery of Autologous and Allogenic Cells to the Heart
April 27, 2020
BioCardia Announces Litigation Financing in the Case Captioned Boston Scientific Corp., et al., v. BioCardia Inc.
April 13, 2020
BioCardia reports 2019 financial results and recent business highlights
April 8, 2020
BioCardia announces positive DSMB recommendation to continue phase iii pivotal CardiAMP heart failure study, as planned
March 30, 2020
BioCardia announces timing for prespecified data safety monitoring board report on pivotal CardiAMP heart failure trial
March 11, 2020
Biocardia Announces FDA Clearance for Morph DNA Deflectable Guide Catheter
January 13, 2020
BioCardia Announces New U.S. Patent Covering CardiAMP Cell Therapy and Issuance of Two Asian Patents Covering Radial Artery Approach for Cardiac Cell and Gene Therapy Delivery
January 7, 2020